Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axonics Inc (AXNX)

Axonics Inc (AXNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,515,140
  • Shares Outstanding, K 51,018
  • Annual Sales, $ 366,380 K
  • Annual Income, $ -6,090 K
  • 60-Month Beta 0.81
  • Price/Sales 9.63
  • Price/Cash Flow 544.94
  • Price/Book 5.47
Trade AXNX with:

Options Overview Details

View History
  • Implied Volatility 27.32% ( -4.86%)
  • Historical Volatility 3.29%
  • IV Percentile 68%
  • IV Rank 38.87%
  • IV High 69.70% on 10/12/23
  • IV Low 0.38% on 03/08/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 21
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 3,587
  • Open Int (30-Day) 3,339

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.13
  • Number of Estimates 6
  • High Estimate 0.20
  • Low Estimate 0.07
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.31 +0.60%
on 09/18/24
69.30 -0.84%
on 08/20/24
-0.11 (-0.16%)
since 08/16/24
3-Month
67.01 +2.55%
on 06/27/24
69.30 -0.84%
on 08/20/24
+1.21 (+1.79%)
since 06/18/24
52-Week
48.30 +42.28%
on 10/30/23
69.68 -1.38%
on 01/08/24
+10.21 (+17.45%)
since 09/18/23

Most Recent Stories

More News
Axonics: Q2 Earnings Snapshot

Axonics: Q2 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Axonics: Q1 Earnings Snapshot

Axonics: Q1 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Axonics: Q4 Earnings Snapshot

Axonics: Q4 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Why Axonics Stock Soared Today

The medical device maker agreed to be acquired by Boston Scientific.

AXNX : 68.72 (-0.26%)
BSX : 82.57 (+0.06%)
Axonics: Q3 Earnings Snapshot

Axonics: Q3 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Why Shares of Axonics Rose Friday

The company showed improved revenue and margins in its second-quarter report.

MDT : 88.13 (-0.56%)
AXNX : 68.72 (-0.26%)
Axonics: Q2 Earnings Snapshot

Axonics: Q2 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Axonics: Q1 Earnings Snapshot

Axonics: Q1 Earnings Snapshot

AXNX : 68.72 (-0.26%)
Axonics Reports First Quarter 2023 Financial Results

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results...

AXNX : 68.72 (-0.26%)
Axonics to Participate in Upcoming Investor Conferences

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in...

AXNX : 68.72 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA.

See More

Key Turning Points

3rd Resistance Point 69.86
2nd Resistance Point 69.47
1st Resistance Point 69.09
Last Price 68.72
1st Support Level 68.33
2nd Support Level 67.94
3rd Support Level 67.56

See More

52-Week High 69.68
Last Price 68.72
Fibonacci 61.8% 61.51
Fibonacci 50% 58.99
Fibonacci 38.2% 56.47
52-Week Low 48.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar